Internal Medicine, Cardiovascular Disease · Carolina, PR
NPI
1932196151
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3018 Ave Isla Verde
Carolina, PR, 00979
Phone (787) 726-7438
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,488 services
Medicare patients, 2024
157
Average age 76
Drug cost, 2024
$652K
14,517 prescriptions
Company payments, 2025
$480
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan C Vila was code J0153 (injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)), 860 times for 20 patients. In total Juan C Vila billed 1,488 services in 18 codes, and Medicare paid $58K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-29.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 860 | 20 | $0.41 | $355 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 154 | 77 | $91.17 | $14K |
| 93000 Electrocardiogram | Office | 125 | 85 | $7.61 | $951 |
| 99214 Office E&M - Established | Office | 106 | 68 | $75.24 | $7,975 |
| 93015 Electrocardiogram | Office | 78 | 78 | $49.04 | $3,825 |
| 78452 Myocardial Perfusion Scan | Office | 75 | 75 | $322.32 | $24K |
| 99213 Office E&M - Established | Office | 35 | 28 | $53.00 | $1,855 |
| 93306 Echocardiography (TTE/TEE) | Office | 22 | 22 | $129.04 | $2,839 |
By year: 2022 $46K for 973 services; 2023 $50K for 1,550 services; 2024 $58K for 1,488 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Vila prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,471 prescriptions and refills. In total Juan C Vila wrote 14,517 Medicare prescriptions that cost $652K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,471 | 2,125 | 318 | $15K |
| Amlodipine Besylate Generic | 1,374 | 1,948 | 286 | $6,275 |
| Metoprolol Succinate Generic | 1,221 | 1,670 | 229 | $14K |
| Atorvastatin Calcium Generic | 1,191 | 1,740 | 263 | $9,282 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 738 | 1,049 | 148 | $20K |
| Valsartan Generic | 686 | 973 | 150 | $14K |
| Hydrochlorothiazide Generic | 562 | 768 | 120 | $2,217 |
| Losartan Potassium Generic | 434 | 603 | 98 | $3,660 |
| Lisinopril Generic | 434 | 657 | 99 | $2,533 |
| Simvastatin Generic | 427 | 588 | 89 | $2,713 |
| Ezetimibe Generic | 398 | 528 | 88 | $5,065 |
| Irbesartan Generic | 377 | 518 | 69 | $6,945 |
| Synthroid Levothyroxine Sodium | 333 | 452 | 67 | $21K |
| Ramipril Generic | 331 | 451 | 62 | $2,556 |
| Eliquis Apixaban | 286 | 326 | 52 | $193K |
Brand drugs: - claims; generic drugs: 13,307 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Vila $480 ($480 in general payments such as food, travel and fees) from 8 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $121 |
| Pbg Puerto Rico LLC | 4 | $92.97 |
| Boston Scientific Corporation BSX | 2 | $67.87 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $22 |
| Bayer Puerto Rico Inc. BAYN.DE | 1 | $19.63 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $6.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.